Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Common side effects of Abilify (aripiprazole) include nausea, vomiting, constipation, headache, dizziness, restlessness or inner agitation (akathisia), trouble sleeping, drowsiness, increased appetite with weight gain, and tremor. Less common but more serious effects can include uncontrollable movements (tardive dyskinesia), elevated blood sugar or cholesterol, low blood pressure when standing, new compulsive behaviors such as gambling or binge eating, seizures, and rare neuroleptic malignant syndrome. Risk and severity differ depending on your dose, age, diagnosis, and other medications, so there are several important factors to consider before assuming a symptom is harmless or drug-related, and details on warning signs that need urgent care are explained more fully below.
Because many Abilify side effects overlap with symptoms of anxiety, depression, thyroid problems, or other conditions, guessing can delay the right treatment or lead you to stop a medication too abruptly. Take a free, instant, online symptom check to help clarify what may be driving how you feel and get guidance on the most sensible next steps to discuss with your prescriber.
Last reviewed for medical accuracy: 09/26/2026
Aripiprazole (brand name: Abilify) is an antipsychotic medication used to treat schizophrenia, bipolar disorder, major depressive disorder (as an add-on), and irritability associated with autism. Like any medication, Abilify can cause side effects. Below is a detailed, easy-to-understand overview of what to expect, how often certain reactions occur, and what to do if you notice them.
• Everyone reacts differently.
• Most side effects are mild and improve over time or with dose tweaks.
• Some reactions can be serious—early detection helps keep you safe.
• Keeping a simple diary of any new symptoms makes conversations with your doctor more productive.
These tend to appear early in treatment and often lessen within days to weeks.
These reactions may require more targeted management or dose adjustment.
Some side effects can be life-threatening or cause long-term issues if not treated quickly. Seek emergency care or call your doctor right away if you notice:
Though rare, some people on Abilify report:
If you notice urges or behaviors that feel out of character, talk to your doctor. Early adjustment can prevent harm to your finances, relationships, and health.
Keep a Symptom Diary
Record what you experience, when it happens, how long it lasts, and any triggers or relief strategies.
Stay Hydrated and Eat Well
Good nutrition and fluid intake can minimize dizziness, dry mouth, constipation, and indigestion.
Exercise Regularly
Physical activity helps control weight gain, improves sleep, and reduces restlessness.
Adjust Timing
If drowsiness is a problem, ask your doctor about taking Abilify in the evening. If insomnia or activation occurs, a morning dose may help.
Avoid Alcohol and Recreational Drugs
These can worsen sedation, dizziness, and cognitive side effects.
Follow Up with Routine Lab Work
Regular blood tests can catch changes in blood sugar, cholesterol, and blood cell counts early.
If you experience any serious side effects listed above—especially signs of NMS, severe allergic reactions, suicidal thoughts, or stroke symptoms—call emergency services or go to your nearest emergency department right away.
For non-emergency guidance on new or worsening symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Always discuss any concerns with your healthcare provider, especially if you experience:
Your doctor can adjust your dose, switch medications, or provide supportive treatments to help you stay safe and comfortable.
Most people on Abilify do well, but being informed and proactive helps you catch side effects early and keep your treatment on track. If you ever suspect a life-threatening or serious issue, speak to a doctor immediately. Your health and safety come first.
(References)
* Winans E. Aripiprazole. Am J Health Syst Pharm. 2003 Dec 1;60(23):2437-45. doi: 10.1093/ajhp/60.23.2437. PMID: 14686220.
* Maytal G, Ostacher M, Stern TA. Aripiprazole-related tardive dyskinesia. CNS Spectr. 2006 Jun;11(6):435-9. doi: 10.1017/s1092852900014632. PMID: 16816781.
* Gunasekaran K, Murthi S, Jennings J, Lone N. Aripiprazole-induced hypersensitivity pneumonitis. BMJ Case Rep. 2017 May 9;2017. doi: 10.1136/bcr-2017-219929. Epub 2017 May 9. PMID: 28487307; PMCID: PMC5614109.
* Işik Ü, Çam Ray P. Aripiprazole-Induced Hoarseness: A Case Report. Clin Neuropharmacol. 2019 Mar/Apr;42(2):55-56. doi: 10.1097/WNF.0000000000000320. PMID: 30724787.
* Pirc Marolt T, Kramar B, Bulc Rozman K, Šuput D, Milisav I. Aripiprazole reduces liver cell division. PLoS One. 2020;15(10):e0240754. doi: 10.1371/journal.pone.0240754. Epub 2020 Oct 26. PMID: 33104743; PMCID: PMC7588089.
* Chen A, Copeli F, Metzger E, Cloutier A, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia. Psychiatry Res. 2021 Jan;295:113641. doi: 10.1016/j.psychres.2020.113641. Epub 2020 Dec 13. PMID: 33340800.
* Nikogosyan G, Orias D, Goebert D, Takeshita J, Wang M. Acute Aripiprazole-Associated Liver Injury. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):344-346. doi: 10.1097/JCP.0000000000001372. PMID: 33734168.
* Ahmed NJ, Alshehri AM, Almalki ZS, Alahmari A. Drug-induced weight gain in the last 10 years: a descriptive study. Pharmazie. 2022 Oct 1;77(10):299-301. doi: 10.1691/ph.2022.2408. PMID: 36273256.
* Jha MK, Mathew SJ. Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape. Am J Psychiatry. 2023 Mar 1;180(3):190-199. doi: 10.1176/appi.ajp.20230025. PMID: 36855876.
* Wang D, Schneider-Thoma J, Siafis S, Burschinski A, Dong S, Wu H, Zhu Y, Davis JM, Priller J, Leucht S. Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials. Schizophr Bull. 2024 Jan 1;50(1):132-144. doi: 10.1093/schbul/sbad089. PMID: 37350486; PMCID: PMC10754166.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.